
CAS 1446182-94-0: GDC-0917
Description:GDC-0917, with the CAS number 1446182-94-0, is a small molecule that has been investigated primarily for its potential therapeutic applications in the treatment of various diseases, particularly in the context of cancer. It functions as a selective inhibitor of certain protein kinases, which play crucial roles in cell signaling pathways that regulate cell growth, proliferation, and survival. The compound's mechanism of action typically involves the modulation of specific targets within these pathways, leading to the inhibition of tumor cell proliferation and induction of apoptosis. GDC-0917 is characterized by its chemical structure, which includes specific functional groups that contribute to its biological activity and selectivity. Additionally, its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are essential for determining its efficacy and safety profile in clinical settings. Ongoing research continues to explore its potential in combination therapies and its effectiveness against various cancer types.
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | CUDC-427 REF: 54-BUP08455CAS: 1446182-94-0 | 98% | 417.00 €~1,615.00 € | Thu 24 Apr 25 |
![]() | CUDC-427 REF: 3D-WHC18294CAS: 1446182-94-0 | Min. 95% | 491.00 €~2,916.00 € | Wed 04 Jun 25 |
![]() | CUDC-427 REF: TM-T15018CAS: 1446182-94-0 | 98.99% | 49.00 €~394.00 € | Wed 11 Jun 25 |

Ref: 54-BUP08455
25mg | 417.00 € | ||
50mg | 588.00 € | ||
100mg | 877.00 € | ||
200mg | 1,615.00 € |

CUDC-427
Ref: 3D-WHC18294
5mg | 491.00 € | ||
10mg | 699.00 € | ||
25mg | 1,170.00 € | ||
50mg | 1,871.00 € | ||
100mg | 2,916.00 € |

CUDC-427
Ref: TM-T15018
1mg | 49.00 € | ||
2mg | 64.00 € | ||
5mg | 97.00 € | ||
10mg | 160.00 € | ||
25mg | 274.00 € | ||
50mg | 394.00 € | ||
1mL*10mM (DMSO) | 125.00 € |